Patent: 10,087,493
✉ Email this page to a colleague
Summary for Patent: 10,087,493
Title: | Method for detecting infectious parvovirus in pharmaceutical preparations |
Abstract: | The present invention provides methods for detecting viral infectivity and content in an enzyme preparation. In certain embodiments, the invention relates to methods for producing a pharmaceutical pancreatic enzyme composition. In additional embodiments, the invention relates to detecting infectious porcine parvovirus (PPV) and determining PPV content in pancreatic enzyme preparations (PEPs), including pancrelipase preparations. |
Inventor(s): | Tijssen; Peter (Pointe-Claire, CA), Szelei; Jozsef (Laval, CA), Zadori; Zoltan (Montreal, CA) |
Assignee: | APTALIS PHARMA CANADA ULC (CA) |
Application Number: | 12/400,145 |
Patent Claims: | see list of patent claims |
Details for Patent 10,087,493
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Organon Usa Inc., A Subsidiary Of Merck & Co., Inc. | COTAZYM | pancrelipase | Capsule, Delayed Release | 020580 | 12/09/1996 | ⤷ Try a Trial | 2040-03-30 |
Abbvie Inc. | CREON | pancrelipase | Capsule, Delayed Release | 020725 | 04/30/2009 | ⤷ Try a Trial | 2040-03-30 |
Abbvie Inc. | CREON | pancrelipase | Capsule, Delayed Release | 020725 | 06/10/2011 | ⤷ Try a Trial | 2040-03-30 |
Abbvie Inc. | CREON | pancrelipase | Capsule, Delayed Release | 020725 | 03/14/2013 | ⤷ Try a Trial | 2040-03-30 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |